Xueni B. Ma

Key Laboratory Of Digestive Diseases
Lanzhou, 730030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

The snoRNA SNORA21 promotes gastric tumorigenesis by attenuating P53 activity through CHK1 phosphorylation inhibition and PERP-dependent feedback loops.

The snoRNA SNORA21 promotes gastric tumorigenesis by attenuating P53 activity through CHK1 phosphorylation inhibition and PERP-dependent feedback loops.

Journal: Cellular signalling

Published: September 11, 2025

Correction: FEZF1-AS1 drives autophagy-mediated progression of colon cancer and reduces chemosensitivity through inhabiting the PI3K/AKT/mTOR signaling pathway.

Correction: FEZF1-AS1 drives autophagy-mediated progression of colon cancer and reduces chemosensitivity through inhabiting the PI3K/AKT/mTOR signaling pathway.

Journal: Frontiers in genetics

Published: August 12, 2025

Enhanced Charge Transfer Process and Chemical Sensing Ability Over a Lattice Rearrangement Strategy via Monatomic Ag Embedded Graphdiyne.

Enhanced Charge Transfer Process and Chemical Sensing Ability Over a Lattice Rearrangement Strategy via Monatomic Ag Embedded Graphdiyne.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: June 20, 2025

Dihydromyricetin/montmorillonite intercalation compounds ameliorates DSS-induced colitis: Role of intestinal epithelial barrier, NLRP3 inflammasome pathway and gut microbiota.

Dihydromyricetin/montmorillonite intercalation compounds ameliorates DSS-induced colitis: Role of intestinal epithelial barrier, NLRP3 inflammasome pathway and gut microbiota.

Journal: International journal of pharmaceutics

Published: October 28, 2024

FEZF1-AS1 drives autophagy-mediated progression of colon cancer and reduces chemosensitivity through inhabiting the PI3K/AKT/mTOR signaling pathway.

FEZF1-AS1 drives autophagy-mediated progression of colon cancer and reduces chemosensitivity through inhabiting the PI3K/AKT/mTOR signaling pathway.

Journal: Frontiers in genetics

Published: October 20, 2024

Focusing on non-responders to infliximab with ulcerative colitis, what can we do first and next?

Focusing on non-responders to infliximab with ulcerative colitis, what can we do first and next?

Journal: International immunopharmacology

Published: May 20, 2024

Sialylation in the gut: From mucosal protection to disease pathogenesis.

Sialylation in the gut: From mucosal protection to disease pathogenesis.

Journal: Carbohydrate polymers

Published: May 07, 2024

Dihydromyricetin ameliorates experimental ulcerative colitis by inhibiting neutrophil extracellular traps formation via the HIF-1α/VEGFA signaling pathway.

Dihydromyricetin ameliorates experimental ulcerative colitis by inhibiting neutrophil extracellular traps formation via the HIF-1α/VEGFA signaling pathway.

Journal: International immunopharmacology

Published: April 08, 2024

Nets in fibrosis: Bridging innate immunity and tissue remodeling.

Nets in fibrosis: Bridging innate immunity and tissue remodeling.

Journal: International immunopharmacology

Published: April 02, 2024

Dihydromyricetin alleviates inflammatory bowel disease associated intestinal fibrosis by inducing autophagy through the PI3K/AKT/mTOR signaling pathway.

Dihydromyricetin alleviates inflammatory bowel disease associated intestinal fibrosis by inducing autophagy through the PI3K/AKT/mTOR signaling pathway.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: September 16, 2023

Assessment of the quality, diagnosis, and therapeutic recommendations of clinical practice guidelines on patients with Helicobacter pylori infection: A systematic review.

Assessment of the quality, diagnosis, and therapeutic recommendations of clinical practice guidelines on patients with Helicobacter pylori infection: A systematic review.

Journal: Gastroenterologia y hepatologia

Published: July 25, 2023

Correction: Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric Cancer.

Correction: Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric Cancer.

Journal: BMC medical genomics

Published: June 16, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026